CCL2 and autosomal dominant polycystic kidney disease: In humans, MCP1 expression increases in PKD1 kidneys, [10] and indeed, high levels of uMCP1 in ADPKD patients have been found [19], which correlated with kidney cyst size, and were suppressed after tolvaptan treatment [25].